Strategic Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,708	Closed	-$2.71M	–	170
2023 Q2	$2.71M	Sell	7,708 -450	-6%	-$152K	0.42%	79
2023 Q1	$2.57M	Sell	8,158 -677	-8%	-$203K	0.41%	79
2022 Q4	$2.55M	Sell	8,835 -141	-2%	-$43K	0.41%	83
2022 Q3	$2.6M	Sell	8,976 -253	-3%	-$72.8K	0.43%	79
2022 Q2	$2.6M	Buy	9,229 +990	+12%	+$265K	0.4%	86
2022 Q1	$2.15M	Buy	8,239 +292	+4%	+$69.3K	0.31%	90
2021 Q4	$1.75M	Buy	7,947 +622	+8%	+$121K	0.23%	108
2021 Q3	$1.33M	Buy	7,325 +1,532	+26%	+$299K	0.19%	117
2021 Q2	$1.17M	Sell	5,793 -633	-10%	-$132K	0.21%	125
2021 Q1	$1.38M	Sell	6,426 -361	-5%	-$79.3K	0.25%	113
2020 Q4	$1.6M	Sell	6,787 -157	-2%	-$36K	0.28%	104
2020 Q3	$1.89M	Buy	6,944 +2,512	+57%	+$693K	0.36%	77
2020 Q2	$1.29M	Buy	4,432 +1,192	+37%	+$323K	0.28%	95
2020 Q1	$771K	Buy	+3,240	New	+$743K	0.2%	102